Zhiyuan Lin
Shanghai, 201210, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Development of a scientific version TPS workflow for BNCT dosimetry based on DICOM and Monte Carlo engine.
Journal: Physical and engineering sciences in medicine
Published: October 14, 2025
Neutron Activation Dose Assessment Based on a Human Head Phantom Post-BNCT.
Journal: Health physics
Published: February 10, 2025
Analysis of the Influence of Boron Distribution on Compound Biological Effectiveness Values in Boron Neutron Capture Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: October 18, 2024
Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib.
Journal: Journal of cancer research and clinical oncology
Published: April 27, 2024
NIR-triggered NO production combined with photodynamic therapy for tumor treatment.
Journal: Photodiagnosis and photodynamic therapy
Published: March 26, 2024
LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: February 19, 2024
Programmable activation of berbamine and photosensitizers for enhanced photodynamic therapy using emission-switchable upconversion nanoparticles.
Journal: International journal of pharmaceutics
Published: January 12, 2024
Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 06, 2021
Tumor-infiltrating TNFRSF9+ CD8+ T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response.
Journal: Oncoimmunology
Published: November 12, 2020
Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer.
Journal: Journal for immunotherapy of cancer
Published: July 17, 2020
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
Journal: International journal of cancer
Published: December 27, 2019
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: December 11, 2019
Last Updated: 09/26/2026